Tekla Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-213,808
| Closed | -$6.06M | – | 217 |
|
|
2020
Q4 | $6.06M | Buy |
213,808
+127,968
| +149% | +$3.63M | 0.21% | 109 |
|
|
2020
Q3 | $2.16M | Hold |
85,840
| – | – | 0.08% | 152 |
|
|
2020
Q2 | $2.1M | Hold |
85,840
| – | – | 0.08% | 158 |
|
|
2020
Q1 | $1.27M | Hold |
85,840
| – | – | 0.06% | 162 |
|
|
2019
Q4 | $1.39M | Buy |
+85,840
| New | +$1.39M | 0.05% | 170 |
|
|
2018
Q4 | – | Sell |
-77,919
| Closed | -$1.94M | – | 212 |
|
|
2018
Q3 | $1.94M | Hold |
77,919
| – | – | 0.07% | 158 |
|
|
2018
Q2 | $2.14M | Buy |
77,919
+34,590
| +80% | +$950K | 0.08% | 136 |
|
|
2018
Q1 | $1.34M | Buy |
43,329
+11,104
| +34% | +$342K | 0.05% | 152 |
|
|
2017
Q4 | $1.15M | Buy |
+32,225
| New | +$1.15M | 0.04% | 143 |
|
|
2016
Q4 | – | Sell |
-75,000
| Closed | -$1.22M | – | 150 |
|
|
2016
Q3 | $1.22M | Hold |
75,000
| – | – | 0.05% | 131 |
|
|
2016
Q2 | $1.02M | Buy |
75,000
+30,000
| +67% | +$408K | 0.04% | 130 |
|
|
2016
Q1 | $786K | Buy |
+45,000
| New | +$786K | 0.03% | 133 |
|